ABBV - AbbVie Inc.
213.59
-3.070 -1.437%
Share volume: 7,132,162
Last Updated: 03-11-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.03%
PREVIOUS CLOSE
CHG
CHG%
$216.66
-3.07
-0.01%
Summary score
51%
Profitability
35%
Dept financing
33%
Liquidity
59%
Performance
70%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2020 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
20.29%
Return on assets
2.11%
Return on sales
26.43%
Return on invested capital
3.23%
Total debt ratio
91.54%
Debt ratio change over timeo
32.88%
Current Ratio
0.86%
Quick Ratio
0.76%
Cash Position Ratio
0.29%
Short-term ratios 31-Dec-2023 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
1%
Return on sales
16.75%
Return on invested capital
0%
Total debt ratio
95.8%
Debt ratio change over timeo
0%
Current Ratio
0.76%
Quick Ratio
0.66%
Cash Position Ratio
0.26%
Last quarter ratios 31-Dec-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-1.23%
Return on sales
-9.87%
Return on invested capital
0%
Total debt ratio
97.54%
Debt ratio change over time
0%
Current Ratio
0.66%
Quick Ratio
0.55%
Cash Position Ratio
0.14%
Performance ratios (change over 4 years) 31-Dec-2020 - 31-Dec-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
971.87%
Return on assets
21.03%
Return on sales
1166.76%
Return on invested capital
63.43%
Total debt ratio
3287.69%
Debt ratio change over time
32.88%
Current Ratio
33.89%
Quick Ratio
29.94%
Cash Position Ratio
12.2%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ABBV | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | 20.29% | 15.71% | 0% | 0% |
| Return on assets | 2.11% | 4.24% | 0% | 0% |
| Return on sales | 26.43% | 28.08% | 0% | 0% |
| Return on invested capital | 3.23% | 9.78% | 0% | 0% |
| Profitability | 69% | 94% | 0% | 0% |
| Total debt ratio | 91.54% | 81.31% | 0% | 0% |
| Debt ratio change over time | 32.88% | -15.58% | 0% | 0% |
| Dept financing | 50% | 22% | 0% | 0% |
| Current Ratio | 0.76% | 1.25% | 0% | 0% |
| Quick Ratio | 0.66% | 0.96% | 0% | 0% |
| Cash Position Ratio | 0.26% | 0.13% | 0% | 0% |
| Liquididy | 64% | 65% | 0% | 0% |
| Short-term ratios | ABBV | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | 0% | 17.51% | 0% | 0% |
| Return on assets | 1% | 4.29% | 0% | 0% |
| Return on sales | 16.75% | 28.55% | 0% | 0% |
| Return on invested capital | 0% | 11.13% | 0% | 0% |
| Profitability | 20% | 100% | 0% | 0% |
| Total debt ratio | 95.8% | 80.84% | 0% | 0% |
| Debt ratio change over time | 0% | 4.11% | 0% | 0% |
| Dept financing | 25% | 46% | 0% | 0% |
| Current Ratio | 0.76% | 1.25% | 0% | 0% |
| Quick Ratio | 0.66% | 0.96% | 0% | 0% |
| Cash Position Ratio | 0.26% | 0.13% | 0% | 0% |
| Liquididy | 57% | 63% | 0% | 0% |